Без стеснения. Все о чудесном женском теле - Шейла де Лиз

L., Wactawski-Wende J., Wallace R., Wassertheil-Smoller S. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial // JAMA. 2004 Apr 14. Vol. 291 (14). P. 1701–1712.

40. Chen W.Y., Rosner В., Hankinson S.E., Colditz G.A., Willett W.C. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk // JAMA. 2011 Nov 2. Vol. 306(17). P. 1884–1890.

41. Andrew M. Kaunitz and JoAnn E. Manson. Management of Menopausal Symptoms // Obstet Gynecol. 2015 Oct. Vol. 126(4). P. 859–876.

42. Manson J.E., Kaunitz A.M. Menopause Management-Getting Clinical Care Back on Track// N Engl J Med. 2016 Mar 3. Vol. 374(9). P. 803–806.

43. Mikkola T.S., Savolainen-Peltonen H., Tuomikoski P., Hoti R, Vattulainen P., Gissler M., Ylikorkala O. Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study//Menopause. 2016 Nov. Vol. 23(11). P. 1199–1203.

44. Krakowsky Y., Grober E.D. A practical guide to female sexual dysfunction: An evidence-based review for physicians in Canada // Can Urol Assoc J. 2018Jun. Vol. 12(6). P. 211–216.

45. Lethaby A., Marjoribanks J., Kronenberg R, Roberts H., Eden J., Brown J. Phytoestrogens for menopausal vasomotor symptoms // Cochrane Database Syst Rev. 2013 Dec 10. Vol. 12.

46. Newton K.M., Reed S.D., LaCroix A.Z., Grothaus L.C., Ehrlich K., Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial //Ann Intern Med. 2006 Dec 19. Vol. 145(12). P. 869–879.

47. Pinkerton J.V, Sanchez Aguirre R, Blake J., Cosman R, Hodis H.N., Hoffstetter S., Kaunitz A. M., Kingsberg S.A., Maki P.M., Manson J.E., Marchbanks P., McClung M.R., Nachtigall L.E., Nelson L.M., Pace D.T, Reid R.L., Sarrel P.M., Shifren J.L., Stuenkel C.A, Utian W.H. The 2017 hormone therapy position statement of The North American Menopause Society. The NAMS 2017 Hormone Therapy Position Statement Advisory Panel // Menopause. 2017 Jul. Vol. 24(7). P. 728–753.

48. Stuenkel C.A, Davis S.R., Gompel A, Lumsden M.A, Murad M.H., Pinkerton J.V, Santen R.J. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline // J Clin Endocrinol Me-tab. 2015 Nov. Vol. 100(11). P. 3975–4011.

49. Santen R.J., Stuenkel C.A., Burger H.G., Manson J.E. Competency in menopause management: whither goest the internist? // J Womens Health (Larchmt). 2014 Apr. Vol. 23(4). P. 281–285.

50. Gass M., Larson J., Cochrane В., Manson J.E., Lane D., Barnabei V, Ockene J., Stefanick M.L., Mouton С Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials // Menopause. 2018 Mar. Vol. 25(3). P. 252–264.

51. Buhling K.J., von Studnitz F.S., JantkeA., Eulenburg C, MueckA.O. Use of hormone therapy by female gynecologists and female partners of male gynecologists in Germany 8 years after the Women's Health Initiative study: results of a survey // Menopause. 2012 Oct. Vol. 19(10). P. 1088–1091.

52. Biglia N., Cozzarella M., Ponzone R., Marenco D., Maggiorotto R, Fuso L., Sismondi P. Personal use of HRT by postmenopausal women doctors and doctors' wives in the north of Italy// Gynecol Endocrinol. 2004 Mar. Vol. 18(3). P. 165–174.

53. Lindau ST., Gavrilova N. Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing // BMJ. 2010 Mar 9. Vol. 340. P. c810.

54. Goldin, Claudia and Lawrence F. Katz. The power of the pill: Oral contraceptives and women's career and marriage decisions // Journal of Political Economy. 2002. Vol. 110(4). P. 730–770.

55. Institute for Quality and Efficiency in Health Care 2006 Informed Health Online Contraception: Do hormonal contraceptives cause weight gain?

56. Gallo M.F., Lopez L.M., Grimes DA, Carayon R, Schulz K.F., Helmerhorst F.M. Combination contraceptives: effects on weight // Cochrane Database Syst Rev. 2014 Jan 29. Vol. 1.

57. Ojvind Lidegaard, professor of obstetrics and gynaecology, Lars Hou-gaard Nielsen, statistician, Charlotte Wessel Skovlund, data manager and scientific assistant, Finn Egil Skjeldestad, professor of clinical medicine, and Ellen Lmkkegaard, senior registrar in obstetrics and gynaecology. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses// Danish cohort study, 2001-9 BMJ. 2011. Vol. 343. P. d6423.

58. Lidegaard O, Lokkegaard E., Jensen A., Skovlund C.W., Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception // N Engl J Med. 2012 Jun 14. Vol. 366(24). P. 2257–2266.

59. Bianco-Molina A., Monreal M. Venous thromboembolism in women taking hormonal contraceptives // Expert Rev Cardiovasc Ther. 2010 Feb. Vol. 8(2). P. 211–215.

60. Urban M., Banks E., Egger S., Canfell K., O'Connell D., Beral V, Sitas F Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study// PLoS Med. 2012. Vol. 9(3). e1001182.

61. Gierisch J. M., Coeytaux R.R., Urrutia R.P, Havrilesky L.J., Moorman P.G., Lowery W.J., Dinan M., McBroom A.J., Hasselblad V, Sanders G.D., Myers E.R. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review // Cancer Epidemiol Biomarkers Prev. 2013 Nov. Vol. 22(11). P. 1931–1943.

62. Archer J.S., Archer D.F Oral contraceptive efficacy and antibiotic interaction: a myth debunked // J Am Acad Dermatol. 2002 Jun. Vol. 46(6). P. 917–923.

63. Dickinson B.D., Altman R.D., Nielsen N.H., Sterling M.L.; Council on Scientific Affairs, American Medical Association. Drug interactions between oral contraceptives and antibiotics // Obstet Gynecol. 2001 Nov. Vol. 98(5 Pt1). P. 853–860.

64. Dal'Ava N., Bahamondes L, Bahamondes M.V., Bottura B.F., Monteiro I. Body weight and body composition of depot medroxyprogesterone acetate users // Contraception. 2014 Aug. Vol. 90(2). P. 182–187.

65. Dirk Wildemeersch, Norman Goldstuck, Thomas Hasskamp, Sohela Jandi, and Ansgar Pett. Intrauterine device quo vadis? Why intrauterine device use should be revisited particularly in nulliparous women? // J Contracept. 2015. Vol. 6. P. 1–12.

66. Hartmann L.C., Sellers T.A, Frost M.H., Lingle